NDATOPICALCREAMPriority Review
Approved
Jan 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SULFAMYLON (mafenide acetate) is a topical cream antibiotic indicated for adjunctive treatment of burn wounds to reduce bacteria and promote healing. It is applied directly to burned skin to prevent infection and support wound management in acute burn care settings.
$0.052BPart D
LOE ApproachingThis legacy product faces LOE approaching with minimal recent spending ($52K in 2023, 391 claims), suggesting a small, stable commercial team focused on maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SULFAMYLON offers limited growth opportunities given its mature lifecycle and minimal commercial footprint; career value lies in specialty burn care channel expertise and management of legacy product portfolios. This is a stable, niche role best suited for professionals seeking specialized hospital/surgical center engagement rather than career advancement through growth initiatives.
Field Sales Representative (Specialty/Hospital)
Worked on SULFAMYLON at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.